Market Size of Vaginal Slings Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 4.60 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Vaginal Slings Market Analysis
Over the next few years, the vaginal slings market is expected to register a CAGR of 4.6%.
The COVID-19 pandemic had a substantial impact on women's health, both physically and emotionally. The strict lockdowns and government regulations intended to slow down the spread of COVID-19 resulted in a decrease in demand for products across all segments. According to an article published in February 2021, urogynecological patients face particular challenges owing to the inherent vulnerabilities of these populations. Behavioral and medical therapies should be recommended as first-line options and initiated via virtual or remote clinics, which were integral to management during the COVID-19 pandemic. Thus, the COVID-19 outbreak had a negative impact on the vaginal sling market. However, the vaginal sling market is expected to grow during the forecast period due to the increasing prevalence of urinary incontinence, the rise in the geriatric population, and the high demand for minimally invasive surgeries.
According to another article published in the Wiley Online Library in February 2021, with the increase in research, some of the neurological complications that were reported in COVID-19 patients include headache, anosmia, hyposmia, dysgeusia, impaired consciousness, seizures, encephalitis, and demyelinating neuropathy. Inflammation and demyelination in the pudendal nerve can lead to bladder and bowel incontinence. Thus, more patients were diagnosed with urinary inconsistency during the COVID-19 era.
The major factor contributing to the growth of the market is the rising prevalence of urinary incontinence. Numerous factors, such as urinary tract infection, weakening of pelvic floor muscles and urethral sphincters, menopause, pregnancy, and childbirth, lead to the development of urinary incontinence symptoms. For instance, according to an article published in the National Library of Medicine in October 2021, the most common urinary tract infections reported in the elderly population are cystitis (37.6%), followed by asymptomatic bacteriuria (31.9%), pyelonephritis (13.9%), urosepsis (10.2%), and prostatitis (6.4%). Thus, the rising prevalence of urinary tract infections will boost the market in the future.
Furthermore, rising demand for minimally invasive procedures and increasing technological advancements boost the market's growth. The major impediment to market growth, however, is the social stigma associated with the disease, as well as the risks and complications associated with the procedures involving these devices.
Vaginal Slings Industry Segmentation
As per the scope of the vaginal sling procedures, these are types of surgeries that help control stress urinary incontinence. The procedure helps close the urethra and bladder neck. The vaginal slings market is segmented by product type (transobturator slings, tension-free vaginal tape slings, others), end-user (hospitals, ambulatory surgery centers, others), and geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
By Product Type | |
Transobturator Slings | |
Tension-free vaginal tape sling | |
Other Product Types |
By End-User | |
Hospitals | |
Ambulatory Surgery Centers | |
Other End-Users |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Vaginal Slings Market Size Summary
The vaginal slings market is poised for growth over the forecast period, driven by the increasing prevalence of urinary incontinence and the rising geriatric population. The demand for minimally invasive surgeries is also contributing to market expansion. Despite the negative impact of the COVID-19 pandemic, which led to a temporary decline in demand due to lockdowns and the shift to virtual healthcare solutions, the market is expected to recover and grow. The pandemic highlighted the challenges faced by urogynecological patients, but it also underscored the importance of innovative treatment options. The market's growth is further supported by advancements in technology and the development of transobturator slings, which offer reduced risks and improved efficacy compared to traditional methods.
North America is anticipated to lead the vaginal slings market, supported by a large patient pool, a growing geriatric population, and well-established healthcare infrastructure. The region benefits from favorable insurance policies and ongoing investments in healthcare facilities, which are expected to enhance market dynamics. The competitive landscape of the market is characterized by the presence of key players such as Boston Scientific Corporation, Coloplast Corp., and Johnson & Johnson, who are actively engaged in product development and strategic partnerships. These companies are focusing on innovation and expansion to maintain their market positions and cater to the increasing demand for effective urinary incontinence solutions.
Vaginal Slings Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Prevalence of Urinary Incotinence and Rise in Geriatric Population
-
1.2.2 Rise in Demand for Minimally Invasive Surgery and Product Development
-
-
1.3 Market Restraints
-
1.3.1 Social Stigma Associated with the Disease and Risks and Complications from the Procedures
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product Type
-
2.1.1 Transobturator Slings
-
2.1.2 Tension-free vaginal tape sling
-
2.1.3 Other Product Types
-
-
2.2 By End-User
-
2.2.1 Hospitals
-
2.2.2 Ambulatory Surgery Centers
-
2.2.3 Other End-Users
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Vaginal Slings Market Size FAQs
What is the current Vaginal Slings Market size?
The Vaginal Slings Market is projected to register a CAGR of 4.60% during the forecast period (2024-2029)
Who are the key players in Vaginal Slings Market?
Boston Scientific Corporation, Coloplast Corp, Promedon Group, A.M.I. GmbH and Johnson & Johnson are the major companies operating in the Vaginal Slings Market.